Yaying Du

1.6k total citations · 1 hit paper
31 papers, 1.1k citations indexed

About

Yaying Du is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yaying Du has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Yaying Du's work include CAR-T cell therapy research (8 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Ferroptosis and cancer prognosis (6 papers). Yaying Du is often cited by papers focused on CAR-T cell therapy research (8 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Ferroptosis and cancer prognosis (6 papers). Yaying Du collaborates with scholars based in China and United States. Yaying Du's co-authors include Sidi Chen, Xiaoyun Dai, Youssef Errami, Guangchuan Wang, Jonathan J. Park, Ryan D. Chow, Lupeng Ye, Matthew B. Dong, Wenfei Xia and Xiao Hu and has published in prestigious journals such as Cell, Nature Biotechnology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Yaying Du

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy

2022 143 citations Lupeng Ye, Jonathan J. Park et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yaying Du China	16	740	522	255	248	177	31	1.1k
Shuguang Zuo China	18	393 0.5×	274 0.5×	157 0.6×	224 0.9×	102 0.6×	26	794
Tomoki Yamano Japan	18	364 0.5×	540 1.0×	289 1.1×	91 0.4×	140 0.8×	54	972
Ang Cui United States	12	435 0.6×	416 0.8×	377 1.5×	137 0.6×	39 0.2×	24	1.1k
Leonardo Mirandola United States	20	606 0.8×	439 0.8×	512 2.0×	98 0.4×	79 0.4×	58	1.1k
Wencai Ma United States	16	872 1.2×	535 1.0×	570 2.2×	134 0.5×	68 0.4×	39	1.6k
Emily Chan United States	14	380 0.5×	544 1.0×	144 0.6×	151 0.6×	132 0.7×	38	835
Matteo Pallocca Italy	16	562 0.8×	203 0.4×	146 0.6×	277 1.1×	65 0.4×	36	852
Zhongyi Yan China	19	729 1.0×	269 0.5×	200 0.8×	432 1.7×	47 0.3×	43	1.1k
Hyunchul Jung South Korea	14	894 1.2×	357 0.7×	209 0.8×	385 1.6×	121 0.7×	26	1.3k

Countries citing papers authored by Yaying Du

Since Specialization

Citations

This map shows the geographic impact of Yaying Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaying Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaying Du more than expected).

Fields of papers citing papers by Yaying Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaying Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaying Du. The network helps show where Yaying Du may publish in the future.

Co-authorship network of co-authors of Yaying Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yaying Du. A scholar is included among the top collaborators of Yaying Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaying Du. Yaying Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Shuyu, Nan Zhang, Hao Zhang, et al.. (2024). Deciphering the TCF19/miR-199a-5p/SP1/LOXL2 pathway: Implications for breast cancer metastasis and epithelial-mesenchymal transition. Cancer Letters. 597. 216995–216995. 1 indexed citations

Wang, Ge, Yaying Du, Tao Xu, et al.. (2024). Directed differentiation of human embryonic stem cells into parathyroid cells and establishment of parathyroid organoids. Cell Proliferation. 57(8). e13634–e13634. 4 indexed citations

Yang, Xue, Yonglin Wu, Hanning Li, et al.. (2023). Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery. BMC Endocrine Disorders. 23(1). 113–113. 6 indexed citations

Dai, Xiaoyun, Jonathan J. Park, Yaying Du, et al.. (2023). Massively parallel knock-in engineering of human T cells. Nature Biotechnology. 41(9). 1239–1255. 34 indexed citations

Ye, Lupeng, Jonathan J. Park, Lei Peng, et al.. (2022). A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy. Cell Metabolism. 34(4). 595–614.e14. 143 indexed citations breakdown →

Zhang, Jun, Yu Xia, Xiaomei Zhou, et al.. (2022). Current landscape of personalized clinical treatments for triple-negative breast cancer. Frontiers in Pharmacology. 13. 977660–977660. 21 indexed citations

Chen, Li, Yihang Qi, Xiangyi Kong, et al.. (2022). Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy. Frontiers in Nutrition. 8. 786742–786742. 16 indexed citations

Yang, Xue, Ge Wang, Hanning Li, et al.. (2022). Regulation of antitumor miR-205 targets oncogenes: Direct regulation of lymphoid specific helicase and its clinical significance. Life Sciences. 309. 120993–120993. 1 indexed citations

Li, Hanning, Huimin Zhang, Xingrui Li, et al.. (2022). MiR-205-5p/GGCT Attenuates Growth and Metastasis of Papillary Thyroid Cancer by Regulating CD44. Endocrinology. 163(4). 14 indexed citations

10.

Li, Hanning, Xiang Zhou, Ge Wang, et al.. (2021). CAR-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism. 107(4). 1110–1126. 27 indexed citations

11.

Wan, Dongyi, Xin Yang, Ganxun Li, et al.. (2021). A Set of Markers Related to Viral Infection Has a Sex-sensitive Prognostic Value in Papillary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 106(5). e2334–e2346. 3 indexed citations

12.

Wang, Guangchuan, Ryan D. Chow, Lvyun Zhu, et al.. (2020). CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade. Cancer Discovery. 10(12). 1912–1933. 87 indexed citations

13.

Li, Hanning, Yaying Du, Tao Xu, et al.. (2020). TMEM158 May Serve as a Diagnostic Biomarker for Anaplastic Thyroid Carcinoma: An Integrated Bioinformatic Analysis. Current Medical Science. 40(6). 1137–1147. 4 indexed citations

14.

Liu, Yun, Teng Cheng, Yaying Du, Xiao Hu, & Wenfei Xia. (2020). LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15. BMC Molecular and Cell Biology. 21(1). 69–69. 23 indexed citations

15.

Ye, Lupeng, Jonathan J. Park, Matthew B. Dong, et al.. (2019). In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma. Nature Biotechnology. 37(11). 1302–1313. 148 indexed citations

16.

Dai, Xiaoyun, Jonathan J. Park, Yaying Du, et al.. (2019). One-step generation of modular CAR-T cells with AAV–Cpf1. Nature Methods. 16(3). 247–254. 107 indexed citations

17.

Dong, Matthew B., Guangchuan Wang, Ryan D. Chow, et al.. (2019). Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. Cell. 178(5). 1189–1204.e23. 213 indexed citations

18.

Kong, Deguang, Anping Li, Yu Liu, et al.. (2019). SIX1 Activates STAT3 Signaling to Promote the Proliferation of Thyroid Carcinoma via EYA1. Frontiers in Oncology. 9. 1450–1450. 33 indexed citations

19.

Zhang, Jinjun, Yaying Du, Xiaoxue Zhang, Mengchen Li, & Xingrui Li. (2018). Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways. Journal of Cancer. 9(7). 1318–1328. 31 indexed citations

20.

Du, Yaying, Wenfei Xia, Jinjun Zhang, et al.. (2017). Comprehensive analysis of long noncoding RNA–mRNA co-expression patterns in thyroid cancer. Molecular BioSystems. 13(10). 2107–2115. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact